In vitro evaluation of the antifungal efficacy of poloxamer 407-based formulations in an infected nail plate model.
暂无分享,去创建一个
[1] O. Sammour,et al. Novel nail penetration enhancer containing vesicles “nPEVs” for treatment of onychomycosis , 2016, Drug delivery.
[2] F. C. Flores,et al. Essential Oils for Treatment for Onychomycosis: A Mini-Review , 2015, Mycopathologia.
[3] C. Müller-Goymann,et al. In vitro permeation and penetration of ciclopirox olamine from poloxamer 407-based formulations--comparison of isolated human stratum corneum, bovine hoof plates and keratin films. , 2015, International journal of pharmaceutics.
[4] Chandrakantsing V. Pardeshi,et al. Insights into drug delivery across the nail plate barrier , 2014, Journal of drug targeting.
[5] Lusiana,et al. Infected nail plate model made of human hair keratin for evaluating the efficacy of different topical antifungal formulations against Trichophyton rubrum in vitro. , 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[6] C. Grover,et al. An update on treatment of onychomycosis , 2012, Mycoses.
[7] Lusiana,et al. Keratin film made of human hair as a nail plate model for studying drug permeation. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[8] S. Murdan. Enhancing the nail permeability of topically applied drugs , 2008, Expert opinion on drug delivery.
[9] S. Murdan. Drug delivery to the nail following topical application. , 2002, International journal of pharmaceutics.
[10] B. Elewski,et al. A large-scale North American study of fungal isolates from nails: the frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns. , 2000, Journal of the American Academy of Dermatology.
[11] R. Summerbell,et al. Prevalence and epidemiology of onychomycosis in patients visiting physicians' offices: a multicenter canadian survey of 15,000 patients. , 2000, Journal of the American Academy of Dermatology.
[12] E. Haneke,et al. The scope of onychomycosis: epidemiology and clinical features , 1999, International journal of dermatology.
[13] J. Zatz,et al. Structural characteristics and permeability properties of the human nail : A review , 1999 .
[14] G. Faich,et al. Effect of onychomycosis on quality of life. , 1998, Journal of the American Academy of Dermatology.
[15] B. Lippold,et al. In‐vitro Permeability of the Human Nail and of a Keratin Membrane from Bovine Hooves: Prediction of the Penetration Rate of Antimycotics through the Nail Plate and their Efficacy , 1997, The Journal of pharmacy and pharmacology.
[16] B. Lippold,et al. In‐vitro Permeability of the Human Nail and of a Keratin Membrane from Bovine Hooves: Influence of the Partition Coefficient Octanol/Water and the Water Solubility of Drugs on their Permeability and Maximum Flux , 1997, The Journal of pharmacy and pharmacology.
[17] G. Piérard,et al. Treatment of onychomycosis: traditional approaches. , 1993, Journal of American Academy of Dermatology.